VCAN and bronchopulmonary dysplasia: Although the betamethasone-induced reduction in versican levels might lead to reduced air/blood gas barriers, thereby increasing the efficiency of gas transfer, alterations to the visco-elastic properties of lung tissue might make it more susceptible to volutrauma and shear stress injury, increasing the risk of bronchopulmonary dysplasia [24].